Burkhardt, Birgit https://orcid.org/0000-0002-1151-829X
Michgehl, Ulf https://orcid.org/0000-0002-2733-8402
Rohde, Jonas https://orcid.org/0000-0002-3323-4175
Erdmann, Tabea https://orcid.org/0000-0003-2634-9625
Berning, Philipp https://orcid.org/0000-0002-4152-0366
Reutter, Katrin
Rohde, Marius https://orcid.org/0000-0002-1487-525X
Borkhardt, Arndt https://orcid.org/0000-0002-6121-4737
Burmeister, Thomas https://orcid.org/0000-0003-4843-2876
Dave, Sandeep https://orcid.org/0000-0003-4848-9768
Tzankov, Alexandar https://orcid.org/0000-0002-1100-3819
Dugas, Martin
Sandmann, Sarah https://orcid.org/0000-0002-5011-0641
Fend, Falko https://orcid.org/0000-0002-5496-293X
Finger, Jasmin
Mueller, Stephanie
Gökbuget, Nicola
Haferlach, Torsten https://orcid.org/0000-0003-0196-2837
Kern, Wolfgang
Hartmann, Wolfgang https://orcid.org/0000-0002-7609-5021
Klapper, Wolfram https://orcid.org/0000-0001-7208-4117
Oschlies, Ilske https://orcid.org/0000-0002-4003-6855
Richter, Julia
Kontny, Udo https://orcid.org/0000-0002-3072-6772
Lutz, Mathias https://orcid.org/0000-0002-2572-5687
Maecker-Kolhoff, Britta https://orcid.org/0000-0001-8164-514X
Ott, German
Rosenwald, Andreas
Siebert, Reiner
von Stackelberg, Arend https://orcid.org/0000-0002-8103-2631
Strahm, Brigitte https://orcid.org/0000-0002-6086-130X
Woessmann, Wilhelm https://orcid.org/0000-0002-6315-0888
Zimmermann, Martin
Zapukhlyak, Myroslav
Grau, Michael https://orcid.org/0000-0003-1909-0133
Lenz, Georg https://orcid.org/0000-0002-4728-1693
Funding for this research was provided by:
Deutsche Kinderkrebsstiftung (DKS 2014.11, DKS 2016.24)
The work was supported by the Mediziner Kolleg of the Medical Faculty of the University of Muenster (K.R.) and the Clinician-Scientist Program of the Cells In Motion Cluster of Excellence (J.R.).
The work was supported by the Clinician-Scientist Program of the Cells In Motion Cluster of Excellence, University of Muenster.
The work was supported by the Mediziner Kolleg of the Medical Faculty of the University of Muenster.
Article History
Received: 5 October 2021
Accepted: 13 June 2022
First Online: 6 July 2022
Competing interests
: Torsten Haferlach and Wolfgang Kern declare partial ownership of MLL Münchner Leukämielabor GmbH. The remaining authors declare no competing interests.